Ovarian Cancer
Io9 AI-Driven Digital Pathology Test Shows Potential to Inform Breast, Ovarian Cancer Therapy
Premium
The firm hopes to develop its DeepHRD digital pathology test as an alternative to costly companion diagnostics based on next-generation sequencing.
Breast, Ovarian Cancer Contributors Uncovered in TWAS Studies
In a pair of new studies, independent research teams used distinct transcriptome-wide association study approaches to find breast and ovarian cancer contributors.
Genetic Contributors to Ovarian Cancer Subtypes Uncovered in Integrated Genomic Study
Researchers unearthed new and known risk loci for ovarian cancer and ovarian cancer histotypes, and found new candidate causal variants and risk genes.
Delfi Diagnostics' Liquid Biopsy Technology Shows Promise for Ovarian Cancer Screening
The test combining DNA fragmentomics and protein biomarkers had sensitivity ranging from 72 percent to 100 percent for detection of ovarian cancer, depending on disease stage.
Natera Signatera MRD Test Nabs Medicare Coverage for Ovarian, Neoadjuvant Breast Cancer
MolDx extended coverage to ovarian cancer in both the adjuvant and surveillance settings, and to breast cancer in the neoadjuvant setting across all disease subtypes.